ISRG Intuitive Surgical Inc

$572.63

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-12-31
Expected on Jan 22, 2026
Report Time: Unknown Release Time
The Whisper Number
$2.44
Consensus Estimate: $2.25
Revenue Estimate: $2.72B

Latest Earnings Insight

Intuitive Surgical's upcoming earnings report is poised to capture attention, particularly as the company continues to solidify its position in the robotic-assisted surgery market. With a market cap nearing $154 billion, Intuitive Surgical's financial health remains robust, and investors are keenly watching for signs of sustained growth. The EPS estimate stands at $2.00, but the whisper number suggests a more optimistic outlook at $2.28, indicating that market insiders may be expecting stronger performance. Revenue is projected at $2.41 billion, reflecting the company's ongoing expansion and innovation in surgical technology. As Intuitive Surgical prepares to release its results on October 21, the focus will be on whether it can exceed these expectations and maintain its momentum in a competitive landscape.

Updated On 12/31/2025

About Intuitive Surgical Inc

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

Website: https://www.intuitive.com

Sector
LIFE SCIENCES
Industry
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1035267
Address
1020 KIFER ROAD, SUNNYVALE, CA, US
Valuation
Market Cap
$172.95B
P/E Ratio
75.19
PEG Ratio
3.34
Price to Book
10.52
Performance
EPS
$6.42
Dividend Yield
Profit Margin
27.80%
ROE
15.60%
Technicals
50D MA
$528.23
200D MA
$510.97
52W High
$616.00
52W Low
$364.31
Fundamentals
Shares Outstanding
358M
Target Price
$616.10
Beta
1.56

ISRG EPS Estimates vs Actual

Estimated
Actual

ISRG News & Sentiment

Dec 31, 2025 • Finviz NEUTRAL
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CONMED Corporation (CNMD) is positioned for growth due to the increasing adoption of its high-margin platforms like AirSeal and BioBrace, along with rising robotic procedure volumes and expanding penetration of Ambulatory Surgery Centers. Despite facing tariff headwinds and challenges from Intuitive Surgical's new da Vinci 5 system, the company shows promising long-term prospects. Supply-chain improvements are expected to drive both top and bottom-line growth, although margin pressure from tariffs and a longer-than-expected supply-chain recovery remain concerns.
Dec 31, 2025 • MarketBeat NEUTRAL
Intuitive Surgical, Inc. $ISRG Shares Sold by Oak Asset Management LLC
Oak Asset Management LLC significantly reduced its stake in Intuitive Surgical (NASDAQ:ISRG) by 23.8% in Q3, now holding 5,685 shares valued at $2.543 million. This comes amid substantial insider selling, with company executives disposing of shares worth $63.53 million in the last 90 days. Despite the selling activity, Intuitive Surgical exceeded Q3 earnings expectations with $2.40 EPS and $2.51 billion in revenue, though the stock trades at a high P/E ratio of 75.7 and holds a "Moderate Buy" consensus rating from analysts.
Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Generate Investment Management Ltd Invests $5.59 Million in Intuitive Surgical, Inc. $ISRG
Generate Investment Management Ltd initiated a new stake in Intuitive Surgical (NASDAQ:ISRG) during Q3, acquiring 12,500 shares valued at approximately $5.59 million. Intuitive Surgical reported strong Q3 earnings, beating analyst estimates with an EPS of $2.40 and revenue of $2.51 billion, a 22.9% year-over-year increase. Despite heavy institutional ownership, there have been recent insider dispositions, with insiders selling 114,007 shares worth about $63.53 million in the last 90 days.
Dec 31, 2025 • MarketBeat NEUTRAL
Calamos Advisors LLC Reduces Stock Holdings in Intuitive Surgical, Inc. $ISRG
Calamos Advisors LLC reduced its stake in Intuitive Surgical, Inc. by 10.4% in the third quarter of 2025, selling 13,162 shares but still retaining 113,140 shares valued at approximately $50.6 million. Despite insider selling by corporate executives, Intuitive Surgical beat Q3 earnings estimates with $2.40 EPS and $2.51 billion in revenue, leading to a "Moderate Buy" consensus rating from analysts with an average target price of $611.08.
Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Cwm LLC Grows Stock Holdings in Becton, Dickinson and Company $BDX
Cwm LLC significantly increased its holdings in Becton, Dickinson and Company (NYSE:BDX) by 69.1% in the third quarter, bringing their total to 38,205 shares valued at $7.15 million. This move is part of a broader trend of institutional investors adjusting their stakes in the medical instruments supplier. The article also provides a financial overview of Becton, Dickinson and Company, including recent stock performance, dividend increases, and analyst ratings.
Dec 31, 2025 • 富途牛牛 BULLISH
Those Who Invested in Intuitive Surgical (NASDAQ:ISRG) Three Years Ago Are up 117%
Investors who bought shares in Intuitive Surgical (NASDAQ:ISRG) three years ago have seen a substantial return of 117%. This performance is closely aligned with the company's 26% compound earnings per share growth over the same period, suggesting consistent market sentiment. The article also notes a 29% increase in the last quarter and a five-year annual TSR of 17%, indicating a strong long-term track record.
Sentiment Snapshot

Average Sentiment Score:

0.352
50 articles with scored sentiment

Overall Sentiment:

Bullish

ISRG Reported Earnings

Jul 22, 2025
Jun 30, 2025 (Post market)
0.27 Surprise
  • Reported EPS: $2.19
  • Estimate: $1.92
  • Whisper:
  • Surprise %: 14.1%
Apr 22, 2025
Mar 31, 2025 (Post market)
0.08 Surprise
  • Reported EPS: $1.81
  • Estimate: $1.73
  • Whisper:
  • Surprise %: 4.6%
Jan 23, 2025
Dec 31, 2024 (Post market)
0.42 Surprise
  • Reported EPS: $2.21
  • Estimate: $1.79
  • Whisper:
  • Surprise %: 23.5%
Oct 17, 2024
Sep 30, 2024 (Post market)
0.2 Surprise
  • Reported EPS: $1.84
  • Estimate: $1.64
  • Whisper:
  • Surprise %: 12.2%
Jul 18, 2024
Jun 30, 2024 (Post market)
0.24 Surprise
  • Reported EPS: $1.78
  • Estimate: $1.54
  • Whisper:
  • Surprise %: 15.6%
Apr 18, 2024
Mar 31, 2024 (Post market)
0.09 Surprise
  • Reported EPS: $1.50
  • Estimate: $1.41
  • Whisper:
  • Surprise %: 6.4%
Jan 23, 2024
Dec 31, 2023 (Post market)
0.12 Surprise
  • Reported EPS: $1.60
  • Estimate: $1.48
  • Whisper:
  • Surprise %: 8.1%
Oct 19, 2023
Sep 30, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $1.46
  • Estimate: $1.41
  • Whisper:
  • Surprise %: 3.5%
Jul 20, 2023
Jun 30, 2023 (Post market)
0.09 Surprise
  • Reported EPS: $1.42
  • Estimate: $1.33
  • Whisper:
  • Surprise %: 6.8%

Financials